Compare Quest Diagnostics Inc (DGX) vs Main Street Capital Corporation (MAIN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Main Street Capital Corporation — how do they compare? Quest Diagnostics Inc trades at $230.97 (market cap $25.48B), while Main Street Capital Corporation trades at $53.74 (market cap $5.09B). The key difference: Quest Diagnostics Inc is far larger — about 5× Main Street Capital Corporation's market cap, and Main Street Capital Corporation pays the higher dividend (5.84%). Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and Main Street Capital Corporation for 89 Days on average.
| DGX | MAIN | |
|---|---|---|
Market Cap | $25.48B | $5.09B |
Volume | 941,866 | 524,060 |
Sector | Health | Financials |
52-Week High | $247.45 | $64.60 |
52-Week Low | $173.49 | $49.63 |
Typical Hold Time | 56 Days | 89 Days |
Enterprise Value | $31.23B | $7.54B |
Dividend Yield | 1.49% | 5.84% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.68% today, with a bullish earnings trend after beating EPS estimates for three consecutive quarters. The stock shows a mixed technical picture with a bearish overall signal but trades near key support at $228. Revenue growth accelerated to $11.04B in 2025, and the company maintains solid profitability with a 9.19% net income margin. Recent news highlights growth in consumer testing and a partnership with Apple Health, though Medicare reimbursement cuts pose a headwind.
The outlook is cautiously optimistic, supported by strong fundamentals and a consensus price target of $250 offering 8% upside. Key opportunities include demand for advanced diagnostics and AI adoption, while risks center on regulatory pressure and rising debt levels. Analyst sentiment is mixed with a slight hold bias, reflecting balanced growth prospects against near-term challenges.
Main Street Capital (MAIN) trades at $54.47, showing modest daily gains of 0.54%. The stock faces bearish technical signals with resistance at $55 and support at $54. Fundamentally, MAIN maintains strong profitability with 80.77% net margins and trades at a reasonable P/E of 10.94. Recent earnings show mixed results with a Q2 beat but Q1 miss, while analysts maintain a cautious stance with 73% hold ratings.
The outlook remains balanced - MAIN's consistent dividend payments and strong ROE of 14.92% provide income appeal, but near-term earnings softness and premium valuation create headwinds. Key risks include declining revenue projections for 2026 and negative operating cash flow, requiring careful monitoring of portfolio performance in rising rate environment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Main Street Capital Corporation
Main Street Capital Corp is an investment firm engaged in providing customized debt and equity financing to lower middle market companies and debt capital to middle market companies. The investment portfolio of the company is typically made to support management buyouts, recapitalizations, growth financings, refinancings and acquisitions of companies that operate in diverse industry sectors. The group invests in secured debt investments, equity investments, warrants and other securities of the lower middle market and middle market companies based in the US. Business is functioned through the U.S region and it derives the majority of the income from the source of fee, commission, and interest.
Read more on MAIN →
